Bromochloromethane CAS:74-97-5

Bromochloromethane

Chemical Name:Bromochloromethane
CAS.NO:74-97-5
Synonyms:bromochlorometane
chlorobromomethane
chloromethyl bromide
Molecular Formula:CH2BrCl
Molecular Weight:129.38400
 
Physical and Chemical Properties:
Density:1.991
Melting point:-68ºC
Boiling point:68ºC
Flash point:11ºC
Index of Refraction:1.482
 
Specification:
Appearance:Colorless to pale yellow transparent liquid
Assay(GC):≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



We are professional bromochlorometane manufacturer and chloromethyl bromide supplier in China, We offer quality chlorobromomethane you can fully trust, also we have India factory and producer of chloromethyl bromide,Pls send inquiry of bromochlorometane CAS:74-97-5 to info@nbinno.com if you have any interests, thank you!


Related News: Developing countries such as China and India have good foundations for undertaking global industrial transfers because of their comparative advantages. With the continuous improvement of China’s fine chemical technology level, the types of products and market shares in China’s undertaking industrial transfer have gradually increased.2-Bromopyridine-5-carbaldehyde Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData’s Company Financials database.2-Fluoro-4-methylbenzaldehyde Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData’s Company Financials database.3-(Trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazine Hydrochloride In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase.In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase.